EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Novel Anti-CD44 Variant 3 Monoclonal Antibody C44Mab-6 Was Established for Multiple Applications

Hiroyuki Suzuki iD, Kaishi Kitamura, Nohara Goto, Kenichiro Ishikawa, Tsunenori Ouchida, Tomohiro Tanaka, Mika K Kaneko, Yukinari Kato iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24098411 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Hiroyuki Suzuki und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Pharmacology, Tohoku University Graduate School of Medicine, 2-1 Seiryo-machi, Aoba-ku, Sendai 980-8575, Japan. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Agency for Medical Research and Development, Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cluster of differentiation 44 (CD44) promotes tumor progression through the recruitment of growth factors and the acquisition of stemness, invasiveness, and drug resistance. CD44 has multiple isoforms including CD44 standard (CD44s) and CD44 variants (CD44v), which have common and unique functions in tumor development. Therefore, elucidating the function of each CD44 isoform in a tumor is essential for the establishment of CD44-targeting tumor therapy. We have established various anti-CD44s and anti-CD44v monoclonal antibodies (mAbs) through the immunization of CD44v3–10-overexpressed cells. In this study, we established C44Mab-6 (IgG1, kappa), which recognized the CD44 variant 3-encoded region (CD44v3), as determined via an enzyme-linked immunosorbent assay. C44Mab-6 reacted with CD44v3–10-overexpressed Chinese hamster ovary (CHO)-K1 cells (CHO/CD44v3–10) or some cancer cell lines (COLO205 and HSC-3) via flow cytometry. The apparent KD of C44Mab-6 for CHO/CD44v3–10, COLO205, and HSC-3 was 1.5 × 10−9 M, 6.3 × 10−9 M, and 1.9 × 10−9 M, respectively. C44Mab-6 could detect the CD44v3–10 in Western blotting and stained the formalin-fixed paraffin-embedded tumor sections in immunohistochemistry. These results indicate that C44Mab-6 is useful for detecting CD44v3 in various experiments and is expected for the application of tumor diagnosis and therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, MonoclonalNeoplasmsAnimalsCricetinaeHumansCHO CellsCricetulusImmunohistochemistryProtein IsoformsHyaluronan Receptors

Stichwörter der Autor:innen

CD44CD44 variant 3flow cytometryimmunohistochemistrymonoclonal antibody

Substanzen

Antibodies, MonoclonalProtein IsoformsHyaluronan Receptors

Autor:innen und Institutionen

  • Department of Molecular Pharmacology, Tohoku University Graduate School of Medicine, 2-1 Seiryo-machi, Aoba-ku, Sendai 980-8575, Japan.
  • Department of Antibody Drug Development, Tohoku University Graduate School of Medicine, 2-1 Seiryo-machi, Aoba-ku, Sendai 980-8575, Japan.

ORCID-Profile: Hiroyuki Suzuki, Yukinari Kato

Förderung

  • Japan Agency for Medical Research and Development
  • Japan Society for the Promotion of Science

Zitieren

APA

Suzuki, H., Kitamura, K., Goto, N., Ishikawa, K., Ouchida, T., Tanaka, T., Kaneko, M. K., & Kato, Y. (2023). A Novel Anti-CD44 Variant 3 Monoclonal Antibody C44Mab-6 Was Established for Multiple Applications. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24098411

Vancouver

Suzuki H, Kitamura K, Goto N, Ishikawa K, Ouchida T, Tanaka T, et al. A Novel Anti-CD44 Variant 3 Monoclonal Antibody C44Mab-6 Was Established for Multiple Applications. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24098411

BibTeX
@article{Suzuki2023,
  author = {Suzuki, Hiroyuki and Kitamura, Kaishi and Goto, Nohara and Ishikawa, Kenichiro and Ouchida, Tsunenori and Tanaka, Tomohiro and Kaneko, Mika K and Kato, Yukinari},
  title = {A Novel Anti-CD44 Variant 3 Monoclonal Antibody C44Mab-6 Was Established for Multiple Applications},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24098411}
}
Kostenlos starten →